Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

Last month she underwent a new treatment called produodopa ... There is currently no cure for Parkinson's disease, a condition which causes a range of difficult physical and psychological ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not respond to levodopa, the main treatment for Parkinson's disease. Therefore, the ...